Pathologic response and microdosimetry of 90Y microspheres in man: Review of four explanted whole livers

Rabeneck, 2003, Outcomes of colorectal cancer in the United States: No change in survival (1986–1997), Am J Gastroenterol, 98, 471 El-Serag, 1999, Rising incidence of hepatocellular carcinoma in the United States, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001 El-Serag, 2003, The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update, Ann Intern Med, 139, 817, 10.7326/0003-4819-139-10-200311180-00009 Sailer, 2000, Three dimensional conformal radiotherapy, 236 Herfarth, 2001, Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial, J Clin Oncol, 19, 164, 10.1200/JCO.2001.19.1.164 Dawson, 2001, Partial irradiation of the liver, Semin Radiat Oncol, 11, 240, 10.1053/srao.2001.23485 Dawson, 2000, Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies, J Clin Oncol, 18, 2210, 10.1200/JCO.2000.18.11.2210 Lawrence, 1990, An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy, Int J Radiat Oncol Biol Phys, 19, 1041, 10.1016/0360-3016(90)90031-E Lawrence, 1992, The use of 3-D dose volume analysis to predict radiation hepatitis, Int J Radiat Oncol Biol Phys, 23, 781, 10.1016/0360-3016(92)90651-W Lawrence, 1995, Hepatic toxicity resulting from cancer treatment, Int J Radiat Oncol Biol Phys, 31, 1237, 10.1016/0360-3016(94)00418-K Lawrence, 1996, 3-D conformal radiation therapy in upper gastrointestinal cancer, Front Radiat Ther Oncol, 29, 221, 10.1159/000424721 Lawrence TS, Kessler ML, Robertson JM. Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer. Oncology (Huntingt) 1993;7:51–57; discussion 57–58, 63. Lawrence, 1991, Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine, Int J Radiat Oncol Biol Phys, 20, 555, 10.1016/0360-3016(91)90069-G Ariel, 1965, Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres), Ann Surg, 162, 267, 10.1097/00000658-196508000-00018 Ariel, 1967, Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy, Cancer, 20, 793, 10.1002/1097-0142(1967)20:5<793::AID-CNCR2820200534>3.0.CO;2-I Ariel, 1982, Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes, J Surg Oncol, 20, 151, 10.1002/jso.2930200304 Blanchard, 1964, Treatment of experimental tumors: Utilization of radioactive microspheres, Arch Surg, 89, 406, 10.1001/archsurg.1964.01320020170025 Blanchard, 1965, Treatment of patients with advanced cancer using Y-90 microspheres, Cancer, 18, 375, 10.1002/1097-0142(196503)18:3<375::AID-CNCR2820180314>3.0.CO;2-U Grady, 1979, Internal radiation therapy of hepatic cancer, Dis Colon Rectum, 22, 371, 10.1007/BF02586901 Kennedy, 2001, Preliminary results of outpatient hepatic artery brachytherapy for colorectal hepatic metastases, Eur J Cancer, 37, 289, 10.1016/S0959-8049(01)81560-4 Kennedy AS, Murthy R, Sarfaraz M, et al. Outpatient hepatic artery brachytherapy for primary and secondary hepatic malignancies. Radiology 2001;221P:468. Kennedy AS, Murthy R, Kwok Y, et al. Hepatic artery brachytherapy for unresectable hepatocellular carcinoma: An outpatient treatment approach. Proceedings of the 12th International Congress on Anti-Cancer Treatment. 2002;1:198–199. Kennedy, 2002, Hepatic artery brachytherapy for neuroendocrine carcinoma, Regul Pept, 108, 32 Kennedy AS, Van Echo DA, Murthy R, et al. Colorectal (CRC) liver metastases and hepatocellular carcinoma (HCC) treated with outpatient hepatic artery brachytherapy, TheraSphere: Imaging response and toxicity. Int J Cancer 2002;S13:226–227. Kennedy AS, Salem R. Comparison of two 90Yttrium microsphere agents for hepatic artery brachytherapy. Proceedings of the 14th International Congress on Anti-Cancer Treatment. 2003:156. Murthy R, Line BR, Kennedy AS, et al. Clinical utility of Brehmstrahlung scan (BRM-Scan) after TheraSphere (TS). J Vasc Interv Radiol 2002;13:S2. Murthy R, Kennedy AS, Tucker G, et al. Outpatient trans arterial hepatic ‘low dose rate’ (TAH-LDR) brachytherapy for unresectable hepatocellular carcinoma. Proceedings of American Association for Cancer Research. 2002;43:485. Murthy, 2002, Technical aspects of TheraSphere (TS) infusion, J Vasc Interv Radiol, 13, S2 Van Echo DA, Kennedy AS, Coldwell D. TheraSphere (TS) at 143 Gy median dose for mixed hepatic cancers; feasibility and toxicities. Am Soc Clin Oncol 2001;260a:1038. Coldwell D, Kennedy AS, Van Echo DA, et al. Feasibility of treatment of hepatic tumors utilizing embolization with yttrium-90 glass microspheres. J Vasc Interv Radiol 2001;12:S113. Salem R, Thurston KG, Carr B, et al. Yttrium-90 microspheres: Radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002;13:S223–229. Sarfaraz, 2001, Radiation dose distribution in patients treated with Y-90 microspheres for non-resectable hepatic tumors, Int J Radiat Oncol Biol Phys, 51, 32, 10.1016/S0360-3016(01)01881-8 Carr B, Salem R, Sheetz M, et al. Hepatic arterial yttrium labeled glass microspheres (TheraSphere) as treatment for unresectable HCC in 36 patients. Proceedings of ASCO 2002. Carr, 2002, A novel and safe therapy for advanced-stage hepatocellular carcinoma (HCC): Hepatic arterial 90Yttrium-labeled glass microspheres (TheraSphere), Int J Cancer, 13, 459 Fox, 1991, Dose distribution following selective internal radiation therapy, Int J Radiat Oncol Biol Phys, 21, 463, 10.1016/0360-3016(91)90797-8 Campbell, 2001, Tumor dosimetry in human liver following hepatic yttrium-90 microsphere therapy, Phys Med Biol, 46, 487, 10.1088/0031-9155/46/2/315 Campbell, 2000, Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy, Phys Med Biol, 45, 1023, 10.1088/0031-9155/45/4/316 Lau, 1998, Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres, Int J Radiat Oncol Biol Phys, 40, 583, 10.1016/S0360-3016(97)00818-3 Burton, 1989, Selective internal radiation therapy: Distribution of radiation in the liver, Eur J Cancer Clin Oncol, 25, 1487, 10.1016/0277-5379(89)90109-0 Burton, 1990, Selective internal radiation therapy: Validation of intraoperative dosimetry, Radiology, 175, 253, 10.1148/radiology.175.1.2315490 Burton, 1989, Intraoperative dosimetry of 90Y in liver tissue, Int J Rad Appl Instrum B, 16, 495, 10.1016/0883-2897(89)90062-7 Gray, 2001, Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer, Ann Oncol, 12, 1711, 10.1023/A:1013569329846 Dancey, 2000, Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres, J Nucl Med, 41, 1673 Muller, 1947, Treatment of cancer of the lungs by artificial radioactivity, Experientia, 3, 75, 10.1007/BF02164393 Muller, 1951, A new method for the treatment of cancer of the lungs by means of artificial radioactivity (Zn63 and Au198), Acta Radiol, 35, 449, 10.3109/00016925109136677 Di Matteo G, Gennarelli L, Lenti R. Una nuova metodica per la fissazione elettiva dell' Au198 adsorbio su carbonio in terriori lobari e sublobari. Gazz Intern Med Chir 1962;67:1875. Dogliotti, 1966, Endoarterial regional injection of radioisotopes in the treatment of malignant tumours, IJARI, 17, 51 Caldarola, 1965, Preparation of 32P labelled resin microspheres for radiation treatment of tumors by intraarterial injection, Panminerva Med, 7, 102 Caldarola L, Badellino F, Del Fante FM. L'impiego del P32 nel trattamento chirurgico dei tumori maligni oro-maxillo-faciali. Minerva Stomatol 1966;15:471. Breedis, 1954, The blood supply of neoplasms in the liver, Am J Pathol, 30, 969 Ackerman, 1970, The blood supply of experimental liver metastases I: The distribution of hepatic artery and portal vein blood to “small” and “large” tumors, Surgery, 66, 1067 Lien, 1970, The blood supply of experimental liver metastases II: A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber, Surgery, 68, 334 Meade, 1987, Distribution of different sized microspheres in experimental hepatic tumours, Eur J Cancer Clin Oncol, 23, 37, 10.1016/0277-5379(87)90416-0 Hirst, 1994, Blood flow and its modulation in malignant tumors, 31 Fukumura, 1997, Effect of host microenvironment on the microcirculation of human colon adenocarcinoma, Am J Pathol, 151, 679 Jirtle, 1978, Measurement of mammary tumor blood flow in unanesthetized rats, J Natl Cancer Inst, 60, 811, 10.1093/jnci/60.4.881 Case, 1924, The occurrence of hepatic lesions in patients treated by intensive deep roentgen irradiation, Am J Roentgenol, 12, 27 Hahn, 1951, Liver cirrhosis with ascites, induced in dogs by chronic massive hepatic irradiation with radioactive colloidal gold, Science, 114, 303, 10.1126/science.114.2960.303 Brick, 1955, Effects of million volt irradiation on the gastrointestinal tract, Arch Intern Med, 96, 26, 10.1001/archinte.1955.04430010040004 Doub, 1925, Radiation sickness in dogs, Am J Roentgenol, 13, 54 Doub, 1927, X-rays in the canine liver, Radiology, 8, 142, 10.1148/8.2.142 Bolliger, 1933, Experimental liver disease produced by x-ray irradiation of the exposed organ, J Pathol, 36, 19, 10.1002/path.1700360104 Warren, 1928, Physiological effects of x-rays, Physiol Rev, 8, 114 Ingold, 1965, Radiation hepatitis, Am J Roentgenol, 93, 200 Fajardo, 1980, Pathogenesis of veno-occlusive liver disease after radiation, Arch Pathol Lab Med, 104, 584 Ogata, 1963, Hepatic injury following irradiation: A morphologic study, Tukushima J Exp Med, 9, 240 Reed, 1966, The human liver after radiation injury, Am J Pathol, 48, 597 Kaplan, 1968, Radiation hepatitis: Possible prevention by combined isotopic and external radiation therapy, Radiology, 91, 1214, 10.1148/91.6.1214 Lewin, 1973, Human radiation hepatitis, Arch Pathol, 96, 21 Fajardo LF, Berthrong M, Anderson RE. Liver. In: Radiation pathology. First ed. New York: Oxford University Press; 2001. p. 249–257. Tefft, 1970, Irradiation of the liver in children: Review of experience in the acute and chronic phases and in the intact normal and partially resected, Am J Roentgenol Radiat Ther Nucl Med, 108, 365, 10.2214/ajr.108.2.365 Wollner, 1988, Effects of hepatic arterial yttrium 90 glass microspheres in dogs, Cancer, 61, 1336, 10.1002/1097-0142(19880401)61:7<1336::AID-CNCR2820610711>3.0.CO;2-K Wollner, 1987, Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bromodeoxyuridine infusion in dogs, Cancer Res, 47, 3285 Roberson, 1992, Three-dimensional tumor dosimetry for hepatic Yttrium-90 microsphere therapy, J Nucl Med, 33, 735 Ya, 1961, Isotope localization with tagged microspheres, Surgery, 49, 644 Kim, 1962, The use of radiating microspheres in the treatment of experimental and human malignancy, Surgery, 52, 220 Chamberlain, 1983, Hepatic metastases–a physiological approach to treatment, Br J Surg, 70, 596, 10.1002/bjs.1800701009 Grady, 1963, Localization of radioactivity by intravascular injection of large radioactive particles, Ann Surg, 157, 97, 10.1097/00000658-196301000-00012 Gray, 1990, Tolerance of the liver to the effects of Yttrium-90 radiation, Int J Radiat Oncol Biol Phys, 18, 619, 10.1016/0360-3016(90)90069-V Pillai, 1991, Microscopic analysis of arterial microsphere distribution in rabbit liver and hepatic VX2 tumor, Selective Cancer Therapeutics, 7, 39, 10.1089/sct.1991.7.39 Zavgorodni, 1996, A model for dose estimation in therapy of liver with intraarterial microspheres, Phys Med Biol, 41, 2463, 10.1088/0031-9155/41/11/016 Muller, 1951, A new method for the treatment of cancer of the lungs by means of artificial radioactivity (Zn63 and Au198), Acta Radiol, 35, 449, 10.3109/00016925109136677 Ariel, 1964, Radioactive isotopes for adjuvant cancer therapy, Arch Surg, 89, 244, 10.1001/archsurg.1964.01320020008002 Nolan, 1973, Regional internal radiation for hepatic cancer, Minerva Oncol, 1, 104 Grady, 1975, Internal hepatic radiotherapy: II, Am J Roentgenol Ther Nucl Med, 124, 596, 10.2214/ajr.124.4.596 Nolan, 1975, Internal hepatic radiotherapy: I, Am J Roentgenol Radium Ther Nucl Med, 124, 590, 10.2214/ajr.124.4.590 Stribley, 1983, Internal radiotherapy for hepatic metastases I: The homogeneity of hepatic arterial blood flow, J Surg Res, 34, 17, 10.1016/0022-4804(83)90017-3 Stribley, 1983, Internal radiotherapy for hepatic metastases II: The blood supply to hepatic metastases, J Surg Res, 34, 25, 10.1016/0022-4804(83)90018-5 Anderson, 1991, Regional delivery of microspheres to liver metastases: The effects of particle size and concentration on intrahepatic distribution, Br J Cancer, 64, 1031, 10.1038/bjc.1991.459 Anderson, 1992, Is there a relationship between regional microsphere distribution and hepatic arterial blood flow?, Br J Cancer, 66, 287, 10.1038/bjc.1992.258 Yan, 1993, An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer, Cancer, 72, 3210, 10.1002/1097-0142(19931201)72:11<3210::AID-CNCR2820721113>3.0.CO;2-6 Turner, 1994, 166Ho-microsphere liver radiotherapy: A preclinical SPECT dosimetry study in the pig, Nucl Med Commun, 15, 545, 10.1097/00006231-199407000-00009 Lin, 2000, Effects of 90Y-microspheres on liver tumors: Comparison of intratumoral injection method and intra-arterial injection method, J Nucl Med, 41, 1892